6wks
-
DTaP-IPV-HepB/Hib
-
PCV13
-
RV5
3mo
-
DTaP-IPV-HepB/Hib
-
PCV13
-
RV5
5mo
-
DTaP-IPV-HepB/Hib
-
PCV13
-
RV5
15mo
-
PCV13
-
MMR
-
Hib
4yo
-
MMR
-
DTaP-IPV
11yo
- Tdap
12yo (girls)
- HPV - 3 doses
45yo
- Td
65yo
-
Td
-
influenza
Key
D = diptheria
T = tetanus
aP = acellular pertussis
IPV = inactivated polio vaccine
Hib = Haemophilus influenzae type B
Hep B = Hepaitits B
PCV13 = 13 valent pneumococcal conjugate
RV5 = rotavirus pentavalent
MMR = measles, mumps and rubella
d = adult diptheria
ap = adult acellular
Td = adult tetanus and diptheria
Special groups
-
Hepatitis A
-
transplant
-
children with chronic liver disease
-
clost contacts of hepA cases
-
-
Hepatitis B
-
household or sexual contacts of individuals with chronic hepB infection
-
babies born to mothers with chronic hepB infection
-
hepatitis B immunoglobulin
-
hep B vaccination at birth
-
(within 12hours)
-
both maybe given within 7d
-
require serological testing @ 9mo
-
-
HIV + patients
-
HepC + patients
-
patients following immunosuppression
-
transplant patients
-
dialysis patients
-
-
HPV funded
-
\<26yo with confirmed HIV infection
-
transplant patients
-
-
meningococcal conjugate vaccines, menCCV and MCV4-D funded
-
pre/post spelenctomy or with functional asplenia
-
HIV, complement def. or pre/post solid organ transplant
-
clost contacts of meningococcal cases
-
bone marrow
-
-
PCV13
-
high risk children who have previously received 4 doses PCV10
-
revaccination immmunosupprssant
-
-
23PPV
-
splenectomy
-
high risk children \<18yo
-
-
Varicella
-
non-immune
-
chronic liver disease who may be candidates for trasnplantation
-
deteriorating renal function prior to transplantatino
-
solid organ transplant
-
elevtive immunosuprression
-
-
2yrs after bone marrow transplant
-
6mo after completino of chemo
-
hiv +
-
inborn error of metabolism
-
household contacts of paeds patient who is immunocompromised
- where no clincial history
-
household ocntact
-
adult immunocompromised
-
no clinc
-
-
-
BCG
-
neonatal
- infants at increase risk of Tb
-